Assessment of spontaneous neuromuscular recovery: A comparison of the TOF-Cuff
neuromuscular blockade
neuromuscular monitoring
rocuronium
Journal
Acta anaesthesiologica Scandinavica
ISSN: 1399-6576
Titre abrégé: Acta Anaesthesiol Scand
Pays: England
ID NLM: 0370270
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
13
03
2019
revised:
05
09
2019
accepted:
22
09
2019
pubmed:
9
10
2019
medline:
9
2
2021
entrez:
9
10
2019
Statut:
ppublish
Résumé
TOF-Cuff Forty patients aged 18-65 years undergoing elective surgery were enrolled. TOF-Cuff The primary outcome could be analysed in 27 patients because of 13 exclusions due to neuromuscular block reversal for shorter procedure surgical time, necessity of reinjection of rocuronium or technical failures of one of the two devices. Median total recovery time with the test device was 45 minutes (interquartile range [IQR] 38.5-61.5) and 63 minutes (IQR 51.1-74.5) with the reference device. Total recovery time with the test device was on average 16.4 minutes shorter (limits of agreement, -6.1 to 39); increasing total recovery time was associated with increasing difference. The TOF ratio of the reference device was on average 0.59 (SD 0.23) when the test device indicated complete recovery. The TOF ratio of the test device was on average 0.98 (SD 0.03) when the reference device indicated complete recovery. When compared with the TOF Watch SX
Sections du résumé
BACKGROUND
TOF-Cuff
METHODS
Forty patients aged 18-65 years undergoing elective surgery were enrolled. TOF-Cuff
RESULTS
The primary outcome could be analysed in 27 patients because of 13 exclusions due to neuromuscular block reversal for shorter procedure surgical time, necessity of reinjection of rocuronium or technical failures of one of the two devices. Median total recovery time with the test device was 45 minutes (interquartile range [IQR] 38.5-61.5) and 63 minutes (IQR 51.1-74.5) with the reference device. Total recovery time with the test device was on average 16.4 minutes shorter (limits of agreement, -6.1 to 39); increasing total recovery time was associated with increasing difference. The TOF ratio of the reference device was on average 0.59 (SD 0.23) when the test device indicated complete recovery. The TOF ratio of the test device was on average 0.98 (SD 0.03) when the reference device indicated complete recovery.
CONCLUSION
When compared with the TOF Watch SX
Substances chimiques
Neuromuscular Nondepolarizing Agents
0
Rocuronium
WRE554RFEZ
Types de publication
Comparative Study
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
173-179Subventions
Organisme : Geneva University Hospitals
Pays : International
Informations de copyright
© 2019 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
Références
Naguib M, Brull SJ, Kopman AF, et al. Consensus statement on perioperative use of neuromuscular monitoring. Anesth Analg. 2017;127:71-80.
Inside view:centro medico teknon. NatureJobs 2016 Nov 23. http://www.nature.com/doifinder/10.1038/nj0500. Accessed March 12, 2019.
Rodiera J, Serradell A, Alvarez-Gomez JA, Aliaga L. The cuff method: a pilot study of a new method of monitoring neuromuscular function. Acta Anaesthesiol Scand. 2005;49:1552-1558.
Veiga Ruiz G, García Cayuela J, Orozco Montes J, Parreño Caparrós M, García Rojo B, Aguayo Albasini JL. Monitoring intraoperative neuromuscular blockade and blood pressure with one device (TOF-Cuff): a comparative study with mechanomyography and invasive blood pressure. Rev Española Anestesiol y Reanim (English Ed). 2017;64:560-567.
Berg H, Viby-Mogensen J, Roed J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. Acta Anaesthesiol Scand. 1997;41:1095-1103.
Fuchs-Buder T, Eikermann M. [Neuromuskuläre Restblockade] Residual neuromuscular blockade. Anaesthesist. 2006;55:7-16.
Eikermann M, Vogt FM, Herbstreit F, et al. The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. Am J Respir Crit Care Med. 2007;175:9-15.
Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107:130-137.
Kirmeier E, Eriksson LI, Lewald H, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. Lancet Respir Med. 2019;7:129-140.
Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007;51:789-808.
Claudius C, Skovgaard LT, Viby-Mogensen J. Is the performance of acceleromyography improved with preload and normalization? A comparison with mechanomyography. Anesthesiology. 2009;110:1261-1270.
Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology. 1998;88:1170-1182.
Capron F, Alla F, Hottier C, Meistelman C, Fuchs-Buder T. Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9. Anesthesiology. 2004;100:1119-1124.
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;327:307-310.
R Development Core Team, R: a language and environment for statistical computing. R Found Stat Comput Vienna Austria.2016.
Krijtenburg P, Honing G, Martini C, et al. Comparison of the TOF-Cuff® monitor with electromyography and acceleromyography during recovery from neuromuscular block. Br J Anaesth. 2018;122:e22-e24.
Cammu G, De Witte J, De Veylder J, et al. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg. 2006;102:426-429.
Kameyama Y, Takagi S, Seto K, et al. Efficiency of the TOF-CuffTM for the evaluation of rocuronium-induced neuromuscular block and its reversal with sugammadex: a comparative study vs. acceleromyography. J Anesth. 2018;33:80-84.
Ibebunjo C, Donati F. Sensitivities of different muscles to relaxant drugs. Baillieres Clin Anaesthesiol. 1994;8:369-394.
Brull SJ, Kopman AF. Current status of neuromuscular reversal and monitoring. Anesthesiology. 2017;126:173-190.
Rudolph MI, Ng PY, Deng H, et al. Comparison of a novel clinical score to estimate the risk of REsidual neuromuscular block Prediction Score and the last train-of-four count documented in the electronic anaesthesia record: a retrospective cohort study of electronic data on file. Eur J Anaesthesiol. 2018;35:883-892.
Bruintjes M, Krijtenburg P, Martini CH, et al;RELAX collaborator group. Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: A randomised controlled trial. Eur J Anaesthesiol. 2019;36:494-501.
Fuchs-Buder T, Schmartz D, Baumann C, et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: a randomised controlled trial. Eur J Anaesthesiol. 2019;36:486-493.